201 related articles for article (PubMed ID: 15126626)
1. Processing and activation of latent heparanase occurs in lysosomes.
Zetser A; Levy-Adam F; Kaplan V; Gingis-Velitski S; Bashenko Y; Schubert S; Flugelman MY; Vlodavsky I; Ilan N
J Cell Sci; 2004 May; 117(Pt 11):2249-58. PubMed ID: 15126626
[TBL] [Abstract][Full Text] [Related]
2. Heparanase processing by lysosomal/endosomal protein preparation.
Cohen E; Atzmon R; Vlodavsky I; Ilan N
FEBS Lett; 2005 Apr; 579(11):2334-8. PubMed ID: 15848168
[TBL] [Abstract][Full Text] [Related]
3. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
Ilan N; Elkin M; Vlodavsky I
Int J Biochem Cell Biol; 2006; 38(12):2018-39. PubMed ID: 16901744
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of activation of human heparanase investigated by protein engineering.
Nardella C; Lahm A; Pallaoro M; Brunetti M; Vannini A; Steinkühler C
Biochemistry; 2004 Feb; 43(7):1862-73. PubMed ID: 14967027
[TBL] [Abstract][Full Text] [Related]
5. Heparanase: one molecule with multiple functions in cancer progression.
Vlodavsky I; Elkin M; Abboud-Jarrous G; Levi-Adam F; Fuks L; Shafat I; Ilan N
Connect Tissue Res; 2008; 49(3):207-10. PubMed ID: 18661344
[TBL] [Abstract][Full Text] [Related]
6. The impact of heparanese and heparin on cancer metastasis and angiogenesis.
Vlodavsky I; Abboud-Jarrous G; Elkin M; Naggi A; Casu B; Sasisekharan R; Ilan N
Pathophysiol Haemost Thromb; 2006; 35(1-2):116-27. PubMed ID: 16855356
[TBL] [Abstract][Full Text] [Related]
7. Proteolytic processing of porcine deoxyribonuclease II occurs in lysosomes but is not required for enzyme activation.
Huang RT; Liao TH; Lu SC
FEBS J; 2009 Apr; 276(7):1891-9. PubMed ID: 19292869
[TBL] [Abstract][Full Text] [Related]
8. Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation.
Zetser A; Bashenko Y; Edovitsky E; Levy-Adam F; Vlodavsky I; Ilan N
Cancer Res; 2006 Feb; 66(3):1455-63. PubMed ID: 16452201
[TBL] [Abstract][Full Text] [Related]
9. Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development.
Vlodavsky I; Goldshmidt O; Zcharia E; Atzmon R; Rangini-Guatta Z; Elkin M; Peretz T; Friedmann Y
Semin Cancer Biol; 2002 Apr; 12(2):121-9. PubMed ID: 12027584
[TBL] [Abstract][Full Text] [Related]
10. Requirement of the conserved, hydrophobic C-terminus region for the activation of heparanase.
Lai NS; Simizu S; Morisaki D; Muroi M; Osada H
Exp Cell Res; 2008 Sep; 314(15):2834-45. PubMed ID: 18662687
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia increases heparanase-dependent tumor cell invasion, which can be inhibited by antiheparanase antibodies.
He X; Brenchley PE; Jayson GC; Hampson L; Davies J; Hampson IN
Cancer Res; 2004 Jun; 64(11):3928-33. PubMed ID: 15173004
[TBL] [Abstract][Full Text] [Related]
12. Biochemical characterization of the active heterodimer form of human heparanase (Hpa1) protein expressed in insect cells.
McKenzie E; Young K; Hircock M; Bennett J; Bhaman M; Felix R; Turner P; Stamps A; McMillan D; Saville G; Ng S; Mason S; Snell D; Schofield D; Gong H; Townsend R; Gallagher J; Page M; Parekh R; Stubberfield C
Biochem J; 2003 Jul; 373(Pt 2):423-35. PubMed ID: 12713442
[TBL] [Abstract][Full Text] [Related]
13. Involvement of disulfide bond formation in the activation of heparanase.
Simizu S; Suzuki T; Muroi M; Lai NS; Takagi S; Dohmae N; Osada H
Cancer Res; 2007 Aug; 67(16):7841-9. PubMed ID: 17699790
[TBL] [Abstract][Full Text] [Related]
14. Activation, processing and trafficking of extracellular heparanase by primary human fibroblasts.
Nadav L; Eldor A; Yacoby-Zeevi O; Zamir E; Pecker I; Ilan N; Geiger B; Vlodavsky I; Katz BZ
J Cell Sci; 2002 May; 115(Pt 10):2179-87. PubMed ID: 11973358
[TBL] [Abstract][Full Text] [Related]
15. Heparanase, heparin and the coagulation system in cancer progression.
Vlodavsky I; Ilan N; Nadir Y; Brenner B; Katz BZ; Naggi A; Torri G; Casu B; Sasisekharan R
Thromb Res; 2007; 120 Suppl 2():S112-20. PubMed ID: 18023704
[TBL] [Abstract][Full Text] [Related]
16. Degradation of basement membrane by prostate tumor heparanase.
Kosir MA; Wang W; Zukowski KL; Tromp G; Barber J
J Surg Res; 1999 Jan; 81(1):42-7. PubMed ID: 9889056
[TBL] [Abstract][Full Text] [Related]
17. Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate.
Vlodavsky I; Ilan N; Naggi A; Casu B
Curr Pharm Des; 2007; 13(20):2057-73. PubMed ID: 17627539
[TBL] [Abstract][Full Text] [Related]
18. Characterization of mechanisms involved in secretion of active heparanase.
Shafat I; Vlodavsky I; Ilan N
J Biol Chem; 2006 Aug; 281(33):23804-11. PubMed ID: 16790442
[TBL] [Abstract][Full Text] [Related]
19. Site-directed mutagenesis, proteolytic cleavage, and activation of human proheparanase.
Abboud-Jarrous G; Rangini-Guetta Z; Aingorn H; Atzmon R; Elgavish S; Peretz T; Vlodavsky I
J Biol Chem; 2005 Apr; 280(14):13568-75. PubMed ID: 15659389
[TBL] [Abstract][Full Text] [Related]
20. Heparanase inhibition reduces proteinuria in a model of accelerated anti-glomerular basement membrane antibody disease.
Levidiotis V; Freeman C; Tikellis C; Cooper ME; Power DA
Nephrology (Carlton); 2005 Apr; 10(2):167-73. PubMed ID: 15877677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]